A 7-year-old girl from rural Rajasthan presents with bilateral eye discharge and mild conjunctival injection for the past 3 weeks. Her mother reports that two younger siblings have similar symptoms. On examination, the child has follicles on the upper tarsal conjunctiva and fine linear scars on the conjunctiva. Giemsa stain of conjunctival scrapings shows intracytoplasmic inclusions within epithelial cells. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Active Trachoma (TF/TI) ### Key Clinical Features Pointing to Trachoma **Key Point:** The combination of rural setting, bilateral follicular conjunctivitis, family clustering, and intracytoplasmic inclusions on Giemsa stain is pathognomonic for active trachoma. ### Diagnostic Criteria This child meets the WHO simplified grading criteria for **Trachomatous Inflammation-Follicular (TF)** or **Trachomatous Inflammation-Intense (TI)**: | Feature | Present in Case | Significance | |---------|-----------------|---------------| | Age group | 7 years old | Peak incidence 1–5 years; common up to age 10 | | Bilateral follicles on upper tarsal conjunctiva | Yes | Hallmark of TF | | Conjunctival scars (linear) | Yes | Indicates repeated or chronic infection | | Intracytoplasmic inclusions (Giemsa) | Yes | Pathognomonic for *Chlamydia trachomatis* | | Family clustering | Yes | Indicates communicable disease in poor sanitation | | Duration | 3 weeks | Consistent with active chlamydial infection | | Geographic setting | Rural Rajasthan | High-endemicity region | ### Pathophysiology **High-Yield:** *Chlamydia trachomatis* serovars A, B, Ba, and C cause trachoma. The organism replicates in conjunctival epithelial cells, triggering a chronic inflammatory response with follicle formation and eventual scarring. **Mnemonic: TF-TI-TS-TT-TE** — WHO simplified grading: - **TF** = Trachomatous Inflammation-Follicular (active, children) - **TI** = Trachomatous Inflammation-Intense (severe active) - **TS** = Trachomatous Scarring (chronic sequela) - **TT** = Trachomatous Trichiasis (eyelash inversion) - **TE** = Trachomatous Epiphora (corneal opacity) ### Confirmatory Investigations 1. **Giemsa stain** — intracytoplasmic inclusions (as seen here) ✓ 2. **PCR/NAAT** — gold standard for *Chlamydia trachomatis* 3. **Direct immunofluorescence** — monoclonal antibodies to chlamydial antigen 4. **Slit-lamp examination** — follicles, Arlt's line (superior limbal scarring in chronic cases) ### Treatment Approach **Clinical Pearl:** WHO recommends **azithromycin 20 mg/kg single dose** for active trachoma in children, or tetracycline eye ointment (1%) for 6 weeks if systemic therapy contraindicated. Mass drug administration (MDA) is indicated in endemic regions. **Key Point:** Early treatment prevents progression to trichiasis, entropion, and blindness.